Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors.
10.3760/cma.j.issn.1671-0274.2019.09.001
- Author:
Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association
- Collective Name:Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents;
adverse effects;
Consensus;
Gastrointestinal Neoplasms;
drug therapy;
Gastrointestinal Stromal Tumors;
drug therapy;
Humans;
Protein Kinase Inhibitors;
adverse effects
- From:
Chinese Journal of Gastrointestinal Surgery
2019;22(9):801-806
- CountryChina
- Language:Chinese
